A Phase III, multicentre, randomized, parallel-group

Project: Research project

Project Details


A Phase III, multicentre, randomized, parallel-group, double blinded, placebo controlled study to evaluate the efficacy and safety of ocrelizumab in adults with Primary Progressive Multiple Sclerosis
Effective start/end date1/1/1112/31/23


  • Genentech Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.